Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
HERON THERAPEUTICS, INC. /DE/ (HRTX)
Standardized SEC financial data for HERON THERAPEUTICS, INC. /DE/ — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000818033 · NASDAQ · Pharmaceutical Preparations.
Gross margin
73.3%
Operating margin
-1.6%
Net margin
-13.0%
Revenue growth (YoY)
7.4%
Return on equity
-140.9%
Free cash flow
-$27.9M
Current ratio
2.48×
EPS (diluted)
$-0.12
Ratios for fiscal year 2025, standardized from SEC filings.